The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

New research suggests that a novel drug molecule could lead to treatments preventing Parkinson’s disease in younger patients.

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

While Parkinson's symptoms—slowed movements ... it will be up to Biogen to apply the results of this new study in future drug development, he said. More information: Véronique Sauvé et ...